The information pre-filling application for the twelfth batch of drug volume procurement has started, involving a total of 76 products and 233 specifications.

On May 15, the National Drug Centralized Purchasing Office issued a notice on the pre-filling of information related to the national organized centralized drug quantity purchasing, marking the official start of the twelfth batch of national organized centralized drug quantity purchasing. Enterprises are required to complete the pre-filling between 14:00 on May 15 and 16:00 on May 21. The listed drugs are varieties and their specifications that meet the competitive conditions until December 31, 2025 and reach a certain purchasing scale. The drug information filled in this time will serve as the selection range for subsequent medical institutions to fill in the demand volume by brand. According to the drug information pre-filling scope announced by the National Drug Centralized Purchasing Office, a total of 76 products and 233 specifications are involved in this batch, setting a new historical record for the number of products since the start of the national organized drug centralized purchasing initiative. Announcement on the pre-filling of information related to the national organized centralized drug quantity purchasing In accordance with the requirements of the standardization and normalization of the national organized centralized drug quantity purchasing system, the National Drug Centralized Purchasing Office has compiled a list of drug varieties that meet the supply structure conditions. In order to facilitate the next centralized purchasing work and allow companies to plan ahead, it has been decided to start the pre-filling of information on relevant drugs before the formal launch of the new batch of drug centralized quantity purchasing. The specific details are announced as follows: I. Range of varieties to be filled Varieties that meet the competitive conditions and have reached a certain purchasing scale by December 31, 2025 (see attachment). II. Filling requirements If the drugs listed in the attachment meet the following conditions, the drug marketing authorization holders can participate in the information filling (overseas marketing authorization holders can have their information filled in by domestic responsible persons or agents): 1. Generic reference drugs published by the National Medical Products Administration; 2. Generic drugs that have undergone quality and efficacy consistency evaluation (including bioequivalence); 3. Drugs that have transferred overseas production of reference drugs to domestic production and comply with relevant regulations. III. Filling content 1. Basic information of the enterprise. Type of enterprise, enterprise name, registered address, legal representative, unified social credit code, business license, etc.; 2. Basic information of the drugs. Variety name, specifications, marketing authorization holder, drug registration approval document, etc.; 3. Information of the authorized person. When the company fills in, it should simultaneously submit the information of the authorized person, including the authorized person's name, telephone, email, authorization letter, etc. Specific materials are subject to platform upload requirements. IV. Filling time and method Filling time: 14:00 on May 15, 2026 to 16:00 on May 21, 2026. Filling method: The National Medical Insurance Service Platform (website: fuwu.nhsa.gov.cn) opens an information filling channel for relevant enterprises. New users of the platform need to click "Register" on the login page, fill in the required information as requested, complete platform account registration, and the user account is valid for a long time without the need for re-registration; existing user accounts need to resubmit or modify qualifications related to this centralized purchasing; after the enterprise logs in to the platform, choose "Drug and Medical Consumables Procurement Service"-"National Organized Drug Centralized Purchasing Information Filling"-"Enterprise Login" to fill in. V. Precautions 1. If the same enterprise has multiple varieties or specifications within the scope of this information filling, all should be filled in. 2. The drug information filled in this time will serve as the selection range for subsequent medical institutions to fill in the demand volume by brand. 3. The final scope of the new batch of national organized centralized drug procurement, qualifications required for enterprise bidding, etc., are subject to the procuremen.t announcement. 4. This pre-filling is an important link in the centralized drug quantity procurement, all enterprises need to pay attention to it, fill in the information of eligible varieties in a timely manner, avoid omissions and errors affecting subsequent participation in centralized quantity procurement and platform listing in various provinces. Other matters will be announced separately, please stay tuned. Contact information: 021-51970737, 51970739, service hours: 8:30-11:30, 13:30-17:00 Attachment: Range of drug pre-filling National Drug Centralized Purchasing Office May 15, 2026 This article is selected from the official website of the National Medical Insurance Administration, GMTEight editor: Feng Qiuyi.